DOT Rule 49 CFR Part 40 Appendix C

Appendix C to Part 40-DOT Drug Testing Semi-Annual Laboratory Report to DOT

Mail, fax, or email to:

U.S. Department of Transportation

Office of Drug and Alcohol Policy and Compliance

W62-300,

1200 New Jersey Avenue, S.E. Washington, DC 20590

Fax: (202) 366-3897

The following items are required on each report:

Reporting Period: (inclusive dates)

Laboratory Identification: (name and address)

1. DOT Specimen Results Reported (total number)

2. Negative Results Reported (total number)

Negative (number)

Negative-Dilute (number)

3. Rejected for Testing Results Reported (total number) By Reason

(a) Fatal flaw (number)

(b) Uncorrected Flaw (number)

4. Positive Results Reported (total number) By Drug

(a) Marijuana Metabolite (number)

(b) Cocaine Metabolite (number)

(1) Codeine (number)

(2) Morphine (number)

(3) 6–AM (number)

(4) Hydrocodone (number)

(5) Hydromorphone (number)

(6) Oxycodone (number)

(7) Oxymorphone (number)

(d) Phencyclidine (number)

(e) Amphetamines (number)

(1) Amphetamine (number)

(2) Methamphetamine (number)

(3) MDMA (number)

div class="rteindent3">(4) MDA (number)

5. Adulterated Results Reported (total number) By Reason (number)

6. Substituted Results Reported (total number)

7. Invalid Results Reported (total number) By Reason (number)

[73 FR 35975, June 25, 2008, as amended 75 FR 49864, August 16, 2010; 82 FR 52247, November 13, 2017]

Last updated: Friday, July 27, 2018